Program. Barcelona 3-4 February 17TH INTERNATIONAL SYMPOSIUM ON INFECTIONS IN THE CRITICALLY ILL PATIENT. the amount of... Euros

Transcription

1 17TH INTERNATIONAL SYMPOSIUM ON INFECTIONS IN THE CRITICALLY ILL PATIENT Barcelona 3-4 February 2012 the amount of... Euros Cancellations must be sent in written to the Technical Secretariat. Before January 7th an administration fee of 30 euros will be debited as management expenses. No fees will be refunded after this date. The participant acknowledges that he/she has no right to lodge damage claims against the organizers should the holding of the Congress be hindered or prevented by unexpected, political or economic events or generally by force majeure, or should the nonappearance of speakers or others reasons necessitate programme changes. With reservation, the participan accepts this proviso. es Program

2 17 TH INTERNATIONAL SYMPOSIUM ON INFECTIONS IN THE CRITICALLY ILL PATIENT Description Advisory Board The aim of this two days symposium is to review current concepts, technology and present advances in infections in the critically ill patients. E. Abraham, MD Birmingham, USA J.Chastre, MD Paris, France H. Giamarellou, MD Athens, Greece Sepsis, Pulmonary Infections, Basic Research, Pulmonary Infections Treatment and Prophylaxis Therapy of severe infections will be the topics of the main sessions presented by experts who will review and update the new advances on infections in the critically ill patient. At the end of each session a Clinical Controversy, Pannel Discussion or Case Report Discussion will be organized. M. Antonelli, MD Rome, Italy E. Bouza, MD Madrid, Spain T. Calandra, MD Lausanne, Switzerland J. Cohen, MD Brighton, UK Garnacho Montero, MD Sevilla, Spain H. Gerlach, MD Berlin, Germany C. Martin, MD Marseille, France J. Pugin, MD Genève, Switzerland J.A. Paiva, MD Porto, Portugal Organized by List of Speakers Antonio Artigas, MD Critical Care Center, Sabadell Hospital, University Institute Parc Taulí, Autonomous University of Barcelona, Spain M. Antonelli, MD Rome (Italy) A. Artigas, MD R. Ferrer, MD J. Garnacho, MD Sevilla (Spain) M. Niederman, MD Mineola (USA) S. Nseir, MD Lille (France) Jean Carlet, MD Direction de l Amélioration de la Qualité et de la Securité des Soins, Paris, France F. Baigorri, MD L. Gattinoni, MD Milano (Italy) A. Paiva, MD Porto (Portugal) Michael Niederman, MD Division of Pulmonary & Critical Care Medicine, Winthrop University Hospital, Mineola, New York, USA E. Bouza, MD Madrid (Spain) Ch. Brun-Buisson, MD H. Gerlach, MD Berlin (Germany) R. Herrero, MD P. Pelosi, MD Genova (Italy) J. Pugin, MD Genève (Switzerland) Antoni Torres, MD Pulmonology Department, Clinic Hospital of Barcelona, Spain T. Calandra, MD Lausanne (Switzerland) J. Carlet, MD M. Levy, MD Rhode Island (USA) GL. Libassi, MD Barcelona (Spain) M. Ranieri, MD Torino (Italy) Th. Rimmele, MD Lyon (France) J. Chastre, MD I. Martin -Loeches, MD Tarragona (Spain) A. Torres, MD Barcelona (Spain) J. Cohen, MD Brighton (UK) JP. Mira, MD S. Toussait, MD Berlin (Germany) M. Ferrer, MD Barcelona (Spain) X. Monnet, MD R. Wunderink, MD Chicago (USA)

3 17 TH INTERNATIONAL SYMPOSIUM ON INFECTIONS IN THE CRITICALLY ILL PATIENT Endorsed by Scientific Program

4 Friday, 3rd February :30 Introduction A. Artigas, MD (Sabadell, Spain), J. Carlet, MD (Paris, France) M. Niederman, MD (Mineola, USA), A. Torres, MD (Barcelona, Spain) I. SEPSIS Moderators: A. Artigas, MD (Sabadell, Spain) J. Cohen, MD (Brighton, UK) A Literature Review. What s Next in Sepsis: Current Trials in Sepsis. J. Cohen, MD (Brighton, UK) Albumin in Septic Patients: Risk or Benefit? JP. Mira, MD (Paris, France) Albumin in Severe Sepsis and Septic Shock : the ALBIOS Study. L. Gattinoni, MD (Milano, Italy) Coffee-break How We Treat Sepsis: Regional Differences M. Levy MD (Rhode Island, USA) apc and Septic Shock: The PROWESS-Shock Study M. Ranieri, MD (Torino, Italy) Anti-TLR Interventions in Severe Sepsis T. Calandra, MD (Lausanne, Switzerland) Use of Lactoferrin as Therapeutic Strategy for Severe Sepsis JP. Mira, MD (Paris, France) Debate: Do We Need Invasive Monitoring in Severe Sepsis? Moderator: F.Baigorri, MD (Sabadell, Spain) Pro: X. Monnet, MD (Paris, France) Con: L. Gattinoni, MD (Milano, Italy) Lunch Satellite Symposium VENTILATOR ACQUIRED PNEUMONIA PREVENTIVE SOLUTIONS, WHAT'S NEW? Topics: 1. Innovation in the endobronchial secretions presence monitoring for the mechanically ventilated patient: Presentation of the Clinical Experience (clinical study), Monza University Hospital, Italy. Dr Zanella, Monza University, Italy 2. Subglottic secretions, when and how to aspirate? Which Protocol? The use of specially designed endotracheal tube: Dr Artigas, Sabadell Hospital, Spain 3. Mobilising secretions to the spontaneous breathing patient? The place of PEEP oscillating therapy in the Rehabilitation Program: Mrs Esperanza Sanchez -Enfermera PAC de Cambre, (A Coruña)-Máster en Ciencias de la Salud-Directora Revista Inspiración SEPAR-Miembro Comité de Congreso SEPAR II. BASIC RESEARCH AND EPIDEMIOLOGY OF SEVERE INFECTIONS Supported by an Educational Grant by Moderators: H. Gerlach, MD (Berlin, Germany) M. Levy, MD (Rhode Island, USA) Danger Signals in SIRS and Sepsis J. Pugin, MD (Genève, Switzerland) Genetic Susceptibility for Pneumonia and CAP R. Wunderink, MD (Chicago, USA) Semi-selective Inmunomodulation Rimmele, MD (Lyon, France) New Mechanisms of Apoptosis in Sepsis and ALI R. Herrero, MD (Sabadell, Spain) Hypoxemia and Inflammation M. Antonelli, MD (Rome, Italy) Coffee-break New Therapies for Acute Lung Injury P. Pelosi, MD (Genova, Italy) Interactive Session: The Sepsis Case Moderator: R. Ferrer, MD (Sabadell, Spain) Expert Panel: - S. Toussaint, MD (Berlin, Germany) - J. Pugin, MD (Genève, Switzerland) - Ch. Brun-Buisson, MD (Paris, France)

5 Satellite Symposium Satellite Symposium PROTOCOL WATCH AND AID TO EARLY AGGRESSIVE RESUSCITATION Saturday, 4th February 2012 III. PULMONARY INFECTIONS Moderator: A. Torres, MD (Barcelona, Spain) A. Paiva, MD (Porto, Portugal) Literature Review: Respiratory Infections R. Wunderink, MD (Chicago, USA) Pseudomonas Aeruginosa: Alternative Approaches Targeting Virulence Factors J. Chastre, MD (Paris, France) Nosocomial ICU Acquired Pneumonia in Non-Ventilated Patients M. Ferrer, MD (Barcelona, Spain) Airway Management to Control VAP GL. Libassi, MD (Barcelona, Spain) Early Tracheostomy and VAP: Risk or Benefit? M. Antonelli, MD (Rome, Italy) Coffee-break Point of Care Microbiological Biomarkers vs Central Laboratory E. Bouza, MD (Madrid, Spain) A Unified Algorithm for Therapy of Pneumonia M. Niederman, MD (Mineola, USA) Defining Severe CAP A. Torres, MD (Barcelona, Spain) Debate: Does VAT Need Therapy? Moderator: J. Chastre, MD (Paris, France) Pro: S. Nseir, MD (Lille, France) Con: R. Wunderink, MD (Chicago, USA) Lunch IV. TREATMENT AND PROPHYLAXIS Moderators: M. Niederman, MD (Mineola, USA), J. Carlet, MD (Paris, France) Interactive Session: The Fungal Infection Case Moderator: M. Antonelli, MD (Rome, Italy) Expert Panel: - J. Garnacho, MD (Sevilla, Spain) - A. Paiva, MD (Porto, Portugal) - T. Calandra, MD (Lausanne, Switzerland) Lessons Learned from Pandemic H1N1 I. Martin-Loeches, MD (Sabadell, Spain) Prevention of Multiresistant Infections: The MOSAR Study Ch. Brun-Buisson, MD (Paris, France) Ethics of Antibiotic Use in the ICU M. Niederman, MD (Mineola, USA) Closing Remarks

6 Registration Form Dates February, 3rd - 4th 2012 Symposium Technical Secretariat McCann Erickson Josep Irla i Boch 1-3, entlo Barcelona, Spain Tel Fax info.infections2012@mccann.es Venue Hotel Rey Juan Carlos I Avda. Diagonal, Barcelona, España Tel Prior to After Members* Non Members Residents** 350 Euros 420 Euros 250 Euros 450 Euros 520 Euros 300 Euros * Members of: ICHS, International Immunocompromised Host Society SEMICYUC, Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias) Ciberes SEPAR SOCMIC The registration fee icludes: Attendance to the Scientific Program and the Comercial Exhibition Conference Documents Certificate of Attendance Coffee Breaks ** A letter signed by the institution responsible is required to get this fee. Members* Non Members Residents** Prior to Euros 420 Euros 250 Euros After Euros 520 Euros 300 Euros * Members of: ICHS, International Immunocompromised Host Society SEMICYUC, Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias) Ciberes SEPAR SOCMIC The registration fee icludes: Attendance to the Scientific Program and the Comercial Exhibition Conference Documents Certificate of Attendance Coffee Breaks ** A letter signed by the institution responsible is required to get this fee. Josep Irla i Boch 1-3, entlo Barcelona, Spain Tel Fax info.infections2012@mccann.es

7 17TH INTERNATIONAL SYMPOSIUM ON INFECTIONS IN THE CRITICALLY ILL PATIENT Barcelona 3-4 February 2012 the amount of... Euros Cancellations must be sent in written to the Technical Secretariat. Before January 7th an administration fee of 30 euros will be debited as management expenses. No fees will be refunded after this date. The participant acknowledges that he/she has no right to lodge damage claims against the organizers should the holding of the Congress be hindered or prevented by unexpected, political or economic events or generally by force majeure, or should the nonappearance of speakers or others reasons necessitate programme changes. With reservation, the participan accepts this proviso. es Program